Mizuho Maintains Outperform on Autolus Therapeutics, Lowers Price Target to $10
AUTOLUS THERAPEUTICS LTD -0.62%
AUTOLUS THERAPEUTICS LTD AUTL | 1.60 | -0.62% |
Mizuho analyst Salim Syed maintains Autolus Therapeutics (NASDAQ:
AUTL) with a Outperform and lowers the price target from $12 to $10.
